As of Apr 29
| -0.025 / -2.50%|
The 4 analysts offering 12-month price forecasts for OncoGenex Pharmaceuticals Inc have a median target of 2.00, with a high estimate of 4.00 and a low estimate of 0.60. The median estimate represents a +105.13% increase from the last price of 0.98.
The current consensus among 4 polled investment analysts is to Buy stock in OncoGenex Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.